Star Announces Alzheimer's Collaboration

Source from:  Tobacco Reporter 04/09/2010

Star Scientific said yesterday it had completed a research and royalty agreement in respect of a compound that may have an application in the treatment of Alzheimer's disease. The agreement, with the Roskamp Institute's affiliate, SRQ Bio, would see the Institute conduct research on a compound developed by Star's Rock Creek Pharmaceutical subsidiary. "Preliminary testing of the compound has produced promising results when applied to cells, and the compound is being explored further for its application to treat a variety of neurological conditions, including Alzheimer's," Star said in a note posted on its website. "Preliminary tests performed by the Roskamp Institute show that when the compound developed by Rock Creek is applied to cells, B-amyloid is reduced. Also, the compound appears to encourage new neuronal cell growth. Results in cells do not necessarily translate to human testing, and additional work needs to be completed to determine whether the compound will have significant B-amyloid lowering effects in humans." Enditem